JP2015525572A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015525572A5 JP2015525572A5 JP2015526635A JP2015526635A JP2015525572A5 JP 2015525572 A5 JP2015525572 A5 JP 2015525572A5 JP 2015526635 A JP2015526635 A JP 2015526635A JP 2015526635 A JP2015526635 A JP 2015526635A JP 2015525572 A5 JP2015525572 A5 JP 2015525572A5
- Authority
- JP
- Japan
- Prior art keywords
- recombinant protein
- surfactant
- propanesulfonate
- sulfobetaine
- ammonio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 17
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 15
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 15
- 239000002888 zwitterionic surfactant Substances 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 8
- 241000700605 Viruses Species 0.000 claims 7
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 claims 6
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 6
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 claims 6
- 239000000693 micelle Substances 0.000 claims 6
- 229940117986 sulfobetaine Drugs 0.000 claims 6
- 102000003390 tumor necrosis factor Human genes 0.000 claims 6
- 238000009472 formulation Methods 0.000 claims 5
- 108091006086 inhibitor proteins Proteins 0.000 claims 4
- 239000004094 surface-active agent Substances 0.000 claims 4
- 238000012258 culturing Methods 0.000 claims 3
- BHATUINFZWUDIX-UHFFFAOYSA-N Zwittergent 3-14 Chemical compound CCCCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O BHATUINFZWUDIX-UHFFFAOYSA-N 0.000 claims 2
- 230000004071 biological effect Effects 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- ZIRURAJAJIQZFG-UHFFFAOYSA-N 1-aminopropane-1-sulfonic acid Chemical compound CCC(N)S(O)(=O)=O ZIRURAJAJIQZFG-UHFFFAOYSA-N 0.000 claims 1
- TUBRCQBRKJXJEA-UHFFFAOYSA-N 3-[hexadecyl(dimethyl)azaniumyl]propane-1-sulfonate Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O TUBRCQBRKJXJEA-UHFFFAOYSA-N 0.000 claims 1
- 108010008165 Etanercept Proteins 0.000 claims 1
- 241000714177 Murine leukemia virus Species 0.000 claims 1
- 241000283984 Rodentia Species 0.000 claims 1
- 239000006143 cell culture medium Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 229960000403 etanercept Drugs 0.000 claims 1
- 230000002779 inactivation Effects 0.000 claims 1
- IZWSFJTYBVKZNK-UHFFFAOYSA-N lauryl sulfobetaine Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-N 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 229940046728 tumor necrosis factor alpha inhibitor Drugs 0.000 claims 1
- 239000002451 tumor necrosis factor inhibitor Substances 0.000 claims 1
- 241001529453 unidentified herpesvirus Species 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261680039P | 2012-08-06 | 2012-08-06 | |
| US61/680,039 | 2012-08-06 | ||
| PCT/US2013/053781 WO2014025771A2 (en) | 2012-08-06 | 2013-08-06 | Methods and compositions for inactivating enveloped viruses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018190622A Division JP6833788B2 (ja) | 2012-08-06 | 2018-10-09 | エンベロープウイルスを不活化するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015525572A JP2015525572A (ja) | 2015-09-07 |
| JP2015525572A5 true JP2015525572A5 (https=) | 2016-09-29 |
| JP6465800B2 JP6465800B2 (ja) | 2019-02-06 |
Family
ID=48986268
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015526635A Active JP6465800B2 (ja) | 2012-08-06 | 2013-08-06 | エンベロープウイルスを不活化するための方法および組成物 |
| JP2018190622A Active JP6833788B2 (ja) | 2012-08-06 | 2018-10-09 | エンベロープウイルスを不活化するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018190622A Active JP6833788B2 (ja) | 2012-08-06 | 2018-10-09 | エンベロープウイルスを不活化するための方法および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US10188732B2 (https=) |
| EP (2) | EP2879691B1 (https=) |
| JP (2) | JP6465800B2 (https=) |
| DK (1) | DK2879691T3 (https=) |
| WO (1) | WO2014025771A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10188732B2 (en) | 2012-08-06 | 2019-01-29 | Biogen Ma Inc. | Methods and compositions for inactivating enveloped viruses |
| CA2961510A1 (en) | 2014-09-17 | 2016-03-24 | Helixbind, Inc. | Methods and devices for detecting and identifying microorganisms |
| AR102198A1 (es) | 2014-10-09 | 2017-02-08 | Regeneron Pharma | Proceso para reducir partículas subvisibles en una formulación farmacéutica |
| EP3420341B1 (en) * | 2016-02-24 | 2020-11-18 | Bio-Rad Laboratories, Inc. | Methods and compositions for fluorescence detection |
| US11020686B2 (en) | 2016-08-16 | 2021-06-01 | Regeneron Pharmaceuticals, Inc. | Methods for quantitating individual antibodies from a mixture |
| JP7102401B2 (ja) | 2016-10-25 | 2022-07-19 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | クロマトグラフィーデータ解析のための方法およびシステム |
| EP3446710A1 (en) * | 2017-08-25 | 2019-02-27 | Glenmark Pharmaceuticals S.A. | Methods of inactivating viral contaminants |
| US11564392B2 (en) | 2017-09-18 | 2023-01-31 | Bayer Healthcare Llc | Methods of inactivation of viruses using n-methlyglucamide and its derivatives |
| CA3073935A1 (en) | 2017-09-19 | 2019-03-28 | Regeneron Pharmaceuticals, Inc. | Methods of reducing particle formation and compositions formed thereby |
| ES2991988T3 (es) | 2017-10-30 | 2024-12-05 | Takeda Pharmaceuticals Co | Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica |
| TWI853823B (zh) | 2018-07-02 | 2024-09-01 | 美商里珍納龍藥品有限公司 | 自混合物製備多肽之系統及方法 |
| WO2020102505A1 (en) | 2018-11-15 | 2020-05-22 | Bayer Healthcare Llc | Viral inactivation methods for continuous manufacturing of antibodies |
| EA202192422A1 (ru) | 2019-03-05 | 2021-12-09 | Ридженерон Фармасьютикалз, Инк. | Человеческий сывороточный альбумин в составах |
| SG11202109801YA (en) * | 2019-03-19 | 2021-10-28 | Amgen Inc | Alternate detergents for viral inactivation |
| CN110424030B (zh) * | 2019-08-30 | 2020-06-30 | 广州三孚新材料科技股份有限公司 | 无氰碱性电镀铜液及其制备和在挠性印刷线路板中的应用 |
| EP4150101A2 (en) * | 2020-05-14 | 2023-03-22 | Merck Patent GmbH | Methods and compositions for purifying adeno associated virus particles or adenoviruses |
| US11643641B2 (en) | 2021-03-04 | 2023-05-09 | Malireddy S. Reddy | Prevention of viral transmission by naked genetic material |
| CN117836010A (zh) | 2021-06-21 | 2024-04-05 | 优尼科生物制药有限公司 | 改进的裂解程序 |
| WO2024115344A1 (en) | 2022-11-29 | 2024-06-06 | Merck Patent Gmbh | Method for inactivating enveloped viruses |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE242716C (https=) | ||||
| DD242716A3 (de) | 1981-08-28 | 1987-02-11 | Adw Der Ddr Inst F Chem Techno | Verfahren zur herstellung von gereinigten antigenen bzw. biopraeparaten |
| DE3704550A1 (de) * | 1987-02-13 | 1988-08-25 | Behringwerke Ag | Verfahren zur inaktivierung huellhaltiger viren in mittels einer zelle in vitro hergestellten protein-praeparationen |
| GB8927546D0 (en) | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
| US5314917A (en) | 1991-03-22 | 1994-05-24 | E. B. Michaels Research Associates, Inc. | Method for inactivating enveloped viruses and sperm |
| FR2805163A1 (fr) | 2000-02-21 | 2001-08-24 | Pf Medicament | Utilisation d'un detergent de type zwittergent pour la preparation d'une composition pharmaceutique destinee a etre administree par voie nasale |
| US6635679B2 (en) * | 2001-05-14 | 2003-10-21 | Akzo Nobel N.V. | Methods and compositions for inactivating viruses |
| CN1901935A (zh) | 2003-12-30 | 2007-01-24 | 惠氏公司 | 具有改进耐受性的免疫原组合物中的疏水性蛋白调配物 |
| NZ568211A (en) * | 2005-11-04 | 2011-11-25 | Novartis Vaccines & Diagnostic | Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
| EP1970440A1 (en) | 2007-03-06 | 2008-09-17 | Qiagen GmbH | Polymerase stabilization by ionic detergents |
| CN103370072B (zh) * | 2010-12-15 | 2016-02-03 | 巴克斯特国际公司 | 使用改进的溶剂-清洁剂方法进行病毒灭活 |
| GB201216121D0 (en) * | 2012-09-10 | 2012-10-24 | Novartis Ag | Sample quantification by disc centrifugation |
| US10188732B2 (en) | 2012-08-06 | 2019-01-29 | Biogen Ma Inc. | Methods and compositions for inactivating enveloped viruses |
-
2013
- 2013-08-06 US US14/419,968 patent/US10188732B2/en active Active
- 2013-08-06 EP EP13750235.7A patent/EP2879691B1/en active Active
- 2013-08-06 WO PCT/US2013/053781 patent/WO2014025771A2/en not_active Ceased
- 2013-08-06 JP JP2015526635A patent/JP6465800B2/ja active Active
- 2013-08-06 DK DK13750235.7T patent/DK2879691T3/da active
- 2013-08-06 EP EP18200752.6A patent/EP3456352A1/en active Pending
-
2018
- 2018-10-09 JP JP2018190622A patent/JP6833788B2/ja active Active
- 2018-12-06 US US16/211,302 patent/US10702603B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015525572A5 (https=) | ||
| JP2016539627A5 (https=) | ||
| JP2015061520A5 (https=) | ||
| MX2020004114A (es) | Formulacion liquida del conjugado de proteina que comprende la oxintomodulina y un fragmento de inmunoglobulina. | |
| EA200870304A1 (ru) | Псевдоинфекционный флавивирус и его применение | |
| WO2009115581A3 (en) | Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells | |
| WO2016070166A3 (en) | Messenger una molecules and uses thereof | |
| WO2013036973A3 (en) | Methods and compositions for controlling assembly of viral proteins | |
| BR112015004696A2 (pt) | polipeptídeos quiméricos tendo especificidade de ligação alvejada | |
| WO2012018639A3 (en) | Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures | |
| JP2015131795A5 (https=) | ||
| MX2013001237A (es) | Compuestos inhibidores del virus de la hepatitis c. | |
| IN2015DN02546A (https=) | ||
| WO2011082388A3 (en) | Infectious dna vaccines against chikungunya virus | |
| WO2013158664A3 (en) | Use of p16 promoter for selective killing of senescent cells | |
| JP2013517776A5 (https=) | ||
| WO2011163628A3 (en) | Dengue virus (dv) polypeptide sequences, t cell epitopes and methods and uses thereof | |
| WO2012075379A3 (en) | Liquid viral formulations | |
| WO2012103524A8 (en) | Inhibitors of mtor kinasa as anti- viral agents | |
| PH12013502177A1 (en) | Hepatitis c virus inhibitors | |
| WO2019088480A3 (ko) | 에티오나마이드를 이용한 줄기세포 이동성 향상 방법 | |
| WO2013104995A3 (en) | Compositions and methods for treating viral infections | |
| WO2012124978A3 (ko) | 3차원 세포배양으로 수득한 조정 배지를 유효성분으로 포함하는 허혈성 질환 치료용 약학적 조성물 | |
| WO2013044023A3 (en) | Citrus tristeza virus based vectors for foreign gene/s expression | |
| EP2600894A4 (en) | MODIFIED HEPATITIS C VIRUS PROTEINS |